Cvs Capsaicin Arthritis Pain Relief
Capsaicin
Cvs
Human Otc Drug
NDC 69842-313Cvs Capsaicin Arthritis Pain Relief also known as Capsaicin is a human otc drug labeled by 'Cvs'. National Drug Code (NDC) number for Cvs Capsaicin Arthritis Pain Relief is 69842-313. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Cvs Capsaicin Arthritis Pain Relief drug includes Capsaicin - .15 g/100g . The currest status of Cvs Capsaicin Arthritis Pain Relief drug is Active.
Drug Information:
| Drug NDC: | 69842-313 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Cvs Capsaicin Arthritis Pain Relief |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Capsaicin |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Cvs |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | CAPSAICIN - .15 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 26 Mar, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | CVS
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 792051
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | S07O44R1ZM
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 69842-313-01 | 1 BOTTLE, WITH APPLICATOR in 1 BOX (69842-313-01) / 28.5 g in 1 BOTTLE, WITH APPLICATOR | 26 Mar, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose arthritis pain relief
Product Elements:
Cvs capsaicin arthritis pain relief capsaicin glycerin capsaicin capsaicin trolamine alcohol propylene glycol water carbomer 940
Indications and Usage:
Uses temporarily relieves minor aches and pains of muscles and joints due to: simple backache arthritis strains bruises sprains
Warnings:
Warnings for external use only do not use on wounds, damaged, broken or irritated skin when using this product use only as directed do not bandage tightly or cover treated area do not use with a heating pad do not get into eyes or on mucous membranes a transient burning sensation may occur upon application but generally disappears in several days if severe burning sensation occurs, discontinue use immediately and read inside of carton for important information do not expose the area treated with product to heat or direct sunlight stop use and ask a doctor if condition gets worse redness is present irritation develops symptoms last for more than 7 days or clear up and occur again within a few days if pregnant or beast-feeding ask a health professional before use. keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.
Do Not Use:
Warnings for external use only do not use on wounds, damaged, broken or irritated skin when using this product use only as directed do not bandage tightly or cover treated area do not use with a heating pad do not get into eyes or on mucous membranes a transient burning sensation may occur upon application but generally disappears in several days if severe burning sensation occurs, discontinue use immediately and read inside of carton for important information do not expose the area treated with product to heat or direct sunlight stop use and ask a doctor if condition gets worse redness is present irritation develops symptoms last for more than 7 days or clear up and occur again within a few days if pregnant or beast-feeding ask a health professional before use. keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.
When Using:
When using this product use only as directed do not bandage tightly or cover treated area do not use with a heating pad do not get into eyes or on mucous membranes a transient burning sensation may occur upon application but generally disappears in several days if severe burning sensation occurs, discontinue use immediately and read inside of carton for important information do not expose the area treated with product to heat or direct sunlight
Dosage and Administration:
Directions apply to affected area place applicator on skin, press firmly and hold to activate the dispensing of liquid massage into painful area until thoroughly absorbed repeat as necessary, but no more than 3 to 4 times daily if medicine comes in contact with hands, wash with soap and water
Stop Use:
Stop use and ask a doctor if condition gets worse redness is present irritation develops symptoms last for more than 7 days or clear up and occur again within a few days
Use in Pregnancy:
If pregnant or beast-feeding ask a health professional before use.
Description:
Please read and keep these directioins what is capsaicin? capsaicin, a naturally occuring substance derived from hot peppers, is a safe and effective topical analgesic for arthritis pain. what does capsaicin do? when applied to the affected area, capsaicin penetrates deep and specically targets pain transmitting neurons by progressively deteriorating their ability to signal pain to the brain, effectively relieving minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains and bruises. when used every day, as directed, the effectiveness of capsaicin continues to build more and more. the amount of time required for pain relief to occur varies with each person. some arthritis sufferers may obtain relief within the rst week of use, while others may experience relief later. this product can be used for all types of arthritis. are there any side effects? due to the nature of capsaicin, a mild tolerable burning and/or itching sensation may be experienced when the product is applied which may last up to 48 hours. this mild burning and/or itching sensation typically diminishes with continued use, and is not a reason to discontinue using this product. severe discomfort has been reported in some individuals. if severe burning and/or itching occurs, discontinue use immediately and remove excess product by thoroughly washing with soap and cold water. if regular soap and water does not completely wash away the residue, try using dishwashing liquid or cooking oil at room temperature. this discomfort can be expected to subside completely. if you experience blistering, or signicant improvement does not occur, stop use and contact your doctor. warm or hot water, direct sunlight or exposure to heat may increase the likelihood of burning and itching. therefore, do not apply immediately before or after activities such as bathing, swimming, using a hot tub, sunbathing or exposure to heat. ⢠if you are a rst time user and think your skin might be sensitive to capsaicin, test it on a small area rst. ⢠children 18 years of age or younger: consult a doctor before using. ⢠wear gloves to apply or, if medicine comes in contact with hands, wash with soap and water after applying to avoid spreading to the eyes or other sensitive areas of the body. try using dishwashing liquid or cooking oil at room temperature if regular soap and water does not completely wash the product from your hands. if product gets into the eyes, ush with water. ⢠apply to affected area and using the applicator, press rmly on skin and hold to activate the dispensing of liquid. massage into painful area until thoroughly absorbed. ⢠if you are using capsaicin on your hands, allow 30 minutes for it to penetrate before washing. during this time avoid touching damaged or irritated skin and avoid contact with the eyes and mucous membranes. after 30 minutes, wash hands with soap and water. ⢠if you wear contact lenses, avoid touching them after applying this product. handle lenses before use. cvs capsaicin facts .jpg
Package Label Principal Display Panel:
Principal display panel cvs health deep penetrating capsaicin0.15% arthritis pain relief ⢠topical analgesic liquid ⢠high potency ⢠odor free compare to the active ingredient in capzasinâ¢* no touch applicator cvs capsaicin .jpg